Biggest changeFINANCIAL STATEMENTS CONSOLIDATED BALANCE SHEETS (In thousands) March 31, March 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 23,360 $ 40,584 Accounts receivable 30,665 20,280 Inventory 36,986 23,666 Prepaid expenses and other current assets 13,429 7,052 Restricted cash 1,733 2,754 Total current assets 106,173 94,336 Property, plant and equipment, net 12,309 13,656 Intangibles, net 8,527 11,311 Right-of-use asset 2,857 3,502 Goodwill 43,471 43,471 Restricted cash 582 6,148 Deferred tax assets 1,114 1,224 Other assets 528 239 Total assets $ 175,561 $ 173,887 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 38,383 $ 29,140 Lease liability, current portion 808 740 Debt, current portion 75 72 Contingent consideration 1,270 1,200 Deferred revenue, current portion 43,572 22,812 Total current liabilities 84,108 53,964 Deferred revenue, long term portion 7,188 7,222 Lease liability, long term portion 2,184 2,900 Deferred tax liabilities 243 297 Debt, long-term portion 15 90 Other liabilities 26 25 Total liabilities 93,764 64,498 Commitments and contingencies (Note 17) Stockholders' equity: Common stock, $ 0.01 par value, 75,000,000 shares authorized; 29,937,119 and 28,919,990 shares issued and 29,539,488 and 28,522,359 shares outstanding at March 31, 2023 and 2022, respectively 299 289 Additional paid-in capital 1,139,113 1,133,536 Treasury stock, at cost, 397,631 at March 31, 2023 and 2022, respectively (3,639 ) (3,639 ) Accumulated other comprehensive income (loss) 1,571 (291 ) Accumulated deficit (1,055,547 ) (1,020,506 ) Total stockholders' equity 81,797 109,389 Total liabilities and stockholders' equity $ 175,561 $ 173,887 The accompanying notes are an integral part of the consolidated financial statements. 35 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) Fiscal Year Ended March 31, 2023 2022 Revenues $ 105,984 $ 108,435 Cost of revenues 97,463 94,943 Gross profit 8,521 13,492 Operating expenses: Research and development 8,966 10,470 Selling, general and administrative 28,700 27,494 Amortization of acquisition related intangibles 2,746 2,467 Change in fair value on contingent consideration 70 (5,850 ) Restructuring 1,048 — Total operating expenses 41,530 34,581 Operating loss (33,009 ) (21,089 ) Interest income, net 252 75 China dissolution (1,921 ) - Other expense, net (148 ) (28 ) Loss before income tax expense (benefit) (34,826 ) (21,042 ) Income tax expense (benefit) 215 (1,849 ) Net loss $ (35,041 ) $ (19,193 ) Net loss per common share Basic $ (1.26 ) $ (0.71 ) Diluted $ (1.26 ) $ (0.71 ) Weighted average number of common shares outstanding Basic 27,848 27,203 Diluted 27,848 27,203 The accompanying notes are an integral part of the consolidated financial statements. 36 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (In thousands) Fiscal Year Ended March 31, 2023 2022 Net loss $ (35,041 ) $ (19,193 ) Other comprehensive (loss) gain, net of tax: China dissolution 1,921 - Foreign currency translation loss (59 ) (14 ) Total other comprehensive (loss) gain, net of tax 1,862 (14 ) Comprehensive loss $ (33,179 ) $ (19,207 ) The accompanying notes are an integral part of the consolidated financial statements. 37 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (In thousands) Common Stock Additional Accumulated Other Total Number of Shares Par Value Paid-in Capital Treasury Stock Comprehensive Income (Loss) Accumulated Deficit Stockholders' Equity Balance at March 31, 2021 27,988 $ 280 $ 1,121,495 $ (3,593 ) $ (277 ) $ (1,001,313 ) $ 116,592 Issuance of common stock - ESPP 28 — $ 241 — — — $ 241 Issuance of common stock - Bonus payments 158 2 2,278 — — — 2,280 Issuance of common stock - restricted shares 404 4 (4 ) — — — — Stock-based compensation expense — — 4,661 — — — 4,661 Issuance of stock for 401(k) match 40 — 481 — — — 481 Issuance of common stock - Neeltran acquisition 302 3 4,384 — — — 4,387 Repurchase of treasury stock — — — (46 ) — — (46 ) Cumulative translation adjustment — — — — (14 ) — (14 ) Net loss — — — — — (19,193 ) (19,193 ) Balance at March 31, 2022 28,920 $ 289 $ 1,133,536 $ (3,639 ) $ (291 ) $ (1,020,506 ) $ 109,389 Issuance of common stock - ESPP 60 1 234 — — — 235 Issuance of common stock - restricted shares 827 8 (8 ) — — — — Stock-based compensation expense — — 4,729 — — — 4,729 Issuance of stock for 401(k) match 130 1 622 — — — 623 Cumulative translation adjustment — — — — 1,862 — 1,862 Net loss — — — — — (35,041 ) (35,041 ) Balance at March 31, 2023 29,937 $ 299 $ 1,139,113 $ (3,639 ) $ 1,571 $ (1,055,547 ) $ 81,797 ) ) The accompanying notes are an integral part of the consolidated financial statements. 38 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Fiscal Year Ended March 31, 2023 2022 Cash flows from operating activities: Net loss $ (35,041 ) $ (19,193 ) Adjustments to reconcile net loss to net cash used in operations: Depreciation and amortization 5,361 5,341 Stock-based compensation expense 4,729 4,661 Provision for excess and obsolete inventory 1,467 1,902 Deferred income taxes 24 (2,403 ) Change in fair value of contingent consideration 70 (5,850 ) China dissolution 1,921 — Non-cash interest income — (49 ) Other non-cash items 600 525 Unrealized foreign exchange gain on cash and cash equivalents (226 ) (186 ) Changes in operating asset and liability accounts: Accounts receivable (10,360 ) (3,760 ) Inventory (14,796 ) (3,307 ) Prepaid expenses and other current assets (5,757 ) (420 ) Accounts payable and accrued expenses 8,660 4,695 Deferred revenue 20,863 (933 ) Net cash used in operating activities (22,485 ) (18,977 ) Cash flows from investing activities: Purchase of property, plant and equipment (1,236 ) (938 ) Cash paid for acquisition, net of cash received — (11,479 ) Proceeds from the maturity of marketable securities — 5,189 Change in other assets (281 ) 65 Net cash used in investing activities (1,517 ) (7,163 ) Cash flows from financing activities: Repurchase of treasury stock — (46 ) Repayment of debt (73 ) (53 ) Proceeds from exercise of employee stock options and ESPP 235 241 Net cash provided by financing activities 162 142 Effect of exchange rate changes on cash, cash equivalents and restricted cash 29 (55 ) Net decrease in cash, cash equivalents and restricted cash (23,811 ) (26,053 ) Cash, cash equivalents and restricted cash at beginning of year 49,486 75,539 Cash, cash equivalents and restricted cash at end of year $ 25,675 $ 49,486 Supplemental schedule of cash flow information: Cash paid for income taxes, net of refunds 350 $ 531 Non-cash investing and financing activities Issuance of common stock in connection with the purchase of Neeltran, Inc. — 4,387 Issuance of common stock to settle liabilities 623 2,761 The accompanying notes are an integral part of the consolidated financial statements. 39 1.
Biggest changeFINANCIAL STATEMENTS CONSOLIDATED BALANCE SHEETS (In thousands) March 31, March 31, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 90,522 $ 23,360 Accounts receivable, net 26,325 30,665 Inventory, net 41,857 36,986 Prepaid expenses and other current assets 7,295 13,429 Restricted cash 468 1,733 Total current assets 166,467 106,173 Property, plant and equipment, net 10,861 12,309 Intangibles, net 6,369 8,527 Right-of-use assets 2,557 2,857 Goodwill 43,471 43,471 Restricted cash 1,290 582 Deferred tax assets 1,119 1,114 Other assets 637 528 Total assets $ 232,771 $ 175,561 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 24,235 $ 38,383 Lease liability, current portion 716 808 Debt, current portion 25 75 Contingent consideration 3,100 1,270 Deferred revenue, current portion 50,732 43,572 Total current liabilities 78,808 84,108 Deferred revenue, long term portion 7,097 7,188 Lease liability, long term portion 1,968 2,184 Deferred tax liabilities 300 243 Debt, long-term portion — 15 Other liabilities 27 26 Total liabilities 88,200 93,764 Commitments and Contingencies (Note 17) Stockholders' equity: Common stock, $ 0.01 par value, 75,000,000 shares authorized; 37,343,812 and 29,937,119 shares issued and 36,946,181 and 29,539,488 shares outstanding at March 31, 2024 and 2023, respectively 373 299 Additional paid-in capital 1,212,913 1,139,113 Treasury stock, at cost, 397,631 at March 31, 2024 and 2023, respectively (3,639 ) (3,639 ) Accumulated other comprehensive income 1,582 1,571 Accumulated deficit (1,066,658 ) (1,055,547 ) Total stockholders' equity 144,571 81,797 Total liabilities and stockholders' equity $ 232,771 $ 175,561 The accompanying notes are an integral part of the consolidated financial statements. 35 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) Fiscal Year Ended March 31, 2024 2023 Revenues $ 145,639 $ 105,984 Cost of revenues 110,356 97,463 Gross profit 35,283 8,521 Operating expenses: Research and development 7,991 8,966 Selling, general and administrative 31,600 28,700 Amortization of acquisition related intangibles 2,152 2,746 Change in fair value on contingent consideration 4,922 70 Restructuring (14 ) 1,048 Total operating expenses 46,651 41,530 Operating loss (11,368 ) (33,009 ) Interest income, net 1,302 252 China dissolution — (1,921 ) Other expense, net (736 ) (148 ) Loss before income tax expense (10,802 ) (34,826 ) Income tax expense 309 215 Net loss $ (11,111 ) $ (35,041 ) Net loss per common share Basic $ (0.37 ) $ (1.26 ) Diluted $ (0.37 ) $ (1.26 ) Weighted average number of common shares outstanding Basic 29,825 27,848 Diluted 29,825 27,848 The accompanying notes are an integral part of the consolidated financial statements. 36 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (In thousands) Fiscal Year Ended March 31, 2024 2023 Net loss $ (11,111 ) $ (35,041 ) Other comprehensive income, net of tax: China dissolution — 1,921 Foreign currency translation gain (loss) 11 (59 ) Total other comprehensive income, net of tax 11 1,862 Comprehensive loss $ (11,100 ) $ (33,179 ) The accompanying notes are an integral part of the consolidated financial statements. 37 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (In thousands) Common Stock Accumulated Other Total Number of Shares Par Value Additional Paid-in Capital Treasury Stock Comprehensive Income (Loss) Accumulated Deficit Stockholders' Equity Balance at March 31, 2022 28,920 $ 289 $ 1,133,536 $ (3,639 ) $ (291 ) $ (1,020,506 ) $ 109,389 Issuance of common stock - ESPP 60 1 234 — — — 235 Issuance of common stock - restricted shares, net of forfeited shares 827 8 (8 ) — — — — Stock-based compensation expense — — 4,729 — — — 4,729 Issuance of stock for 401(k) match 130 1 622 — — — 623 Cumulative translation adjustment — — — — 1,862 — 1,862 Net loss — — — — — (35,041 ) (35,041 ) Balance at March 31, 2023 29,937 $ 299 $ 1,139,113 $ (3,639 ) $ 1,571 $ (1,055,547 ) $ 81,797 Issuance of common stock - ESPP 34 — 279 — — — 279 Issuance of common stock - restricted shares, net of forfeited shares 682 7 (7 ) — — — — Stock-based compensation expense — — 4,652 — — — 4,652 Issuance of stock for 401(k) match 80 1 623 — — — 624 Issuance of common stock for contingent consideration 400 4 3,088 — — — 3,092 Issuance of common stock - equity offering 6,210 62 65,165 — — — 65,227 Cumulative translation adjustment — — — — 11 — 11 Net loss — — — — — (11,111 ) (11,111 ) Balance at March 31, 2024 37,343 $ 373 $ 1,212,913 $ (3,639 ) $ 1,582 $ (1,066,658 ) $ 144,571 The accompanying notes are an integral part of the consolidated financial statements. 38 AMERICAN SUPERCONDUCTOR CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Fiscal Year Ended March 31, 2024 2023 Cash flows from operating activities: Net loss $ (11,111 ) $ (35,041 ) Adjustments to reconcile net loss to net cash used in operations: Depreciation and amortization 4,494 5,361 Stock-based compensation expense 4,652 4,729 Provision for excess and obsolete inventory 1,970 1,467 Deferred income taxes 65 24 Change in fair value of contingent consideration 4,922 70 China dissolution — 1,921 Other non-cash items 44 600 Unrealized foreign exchange gain on cash and cash equivalents (2 ) (226 ) Changes in operating asset and liability accounts: Accounts receivable 4,340 (10,360 ) Inventory (6,841 ) (14,796 ) Prepaid expenses and other current assets 6,313 (5,757 ) Accounts payable and accrued expenses (13,825 ) 8,660 Deferred revenue 7,117 20,863 Net cash provided by (used in) operating activities 2,138 (22,485 ) Cash flows from investing activities: Purchases of property, plant and equipment (934 ) (1,236 ) Change in other assets (27 ) (281 ) Net cash used in investing activities (961 ) (1,517 ) Cash flows from financing activities: Repayment of debt (65 ) (73 ) Proceeds from public equity offering, net 65,227 — Proceeds from exercise of ESPP 279 235 Net cash provided by financing activities 65,441 162 Effect of exchange rate changes on cash, cash equivalents and restricted cash (13 ) 29 Net increase (decrease) in cash, cash equivalents and restricted cash 66,605 (23,811 ) Cash, cash equivalents and restricted cash at beginning of year 25,675 49,486 Cash, cash equivalents and restricted cash at end of year $ 92,280 $ 25,675 Supplemental schedule of cash flow information: Cash paid for income taxes, net of refunds $ 286 $ 350 Non-cash investing and financing activities Issuance of common stock to settle contingent consideration $ 3,092 $ — Issuance of common stock to settle liabilities $ 624 $ 623 The accompanying notes are an integral part of the consolidated financial statements. 39 1.
The following table reconciles the numerators and denominators of the EPS calculation for the fiscal years ended March 31, 2023 and 2022 (in thousands except per share amounts): Fiscal year ended March 31, 2023 2022 Numerator: Net loss $ (35,041 ) $ (19,193 ) Denominator: Weighted-average shares of common stock outstanding 29,038 28,293 Weighted-average shares subject to repurchase (1,190 ) (1,090 ) Shares used in per-share calculation ― basic 27,848 27,203 Shares used in per-share calculation ― diluted 27,848 27,203 Net loss per share ― basic $ (1.26 ) $ (0.71 ) Net loss per share ― diluted $ (1.26 ) $ (0.71 ) Foreign Currency Translation The functional currency of all the Company’s foreign subsidiaries is the U.S. dollar, except for AMSC Austria, for which the local currency (Euro) is the functional currency.
The following table reconciles the numerators and denominators of the EPS calculation for the fiscal years ended March 31, 2024 and 2023 (in thousands except per share amounts): Fiscal year ended March 31, 2024 2023 Numerator: Net loss $ (11,111 ) $ (35,041 ) Denominator: Weighted-average shares of common stock outstanding 31,277 29,038 Weighted-average shares subject to repurchase (1,452 ) (1,190 ) Shares used in per-share calculation ― basic 29,825 27,848 Shares used in per-share calculation ― diluted 29,825 27,848 Net loss per share ― basic $ (0.37 ) $ (1.26 ) Net loss per share ― diluted $ (0.37 ) $ (1.26 ) Foreign Currency Translation The functional currency of all the Company’s foreign subsidiaries is the U.S. dollar, except for AMSC Austria, for which the local currency (Euro) is the functional currency.
The following table provides the assets and liabilities carried at fair value on a recurring basis, measured as of March 31, 2023 and 2022 (in thousands): Total Carrying Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) March 31, 2023: Assets: Cash equivalents $ 7,913 $ 7,913 $ — $ — Derivative liabilities: Contingent Consideration $ 1,270 $ — $ — $ 1,270 Total Carrying Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) March 31, 2022: Assets: Cash equivalents $ 17,641 $ 17,641 $ — $ — Derivative liabilities: Contingent Consideration $ 1,200 $ — $ — $ 1,200 50 The table below reflects the activity for the Company’s major classes of liabilities measured at fair value on a recurring basis (in thousands): Acquisition Contingent Consideration Balance at March 31, 2021 $ 7,050 Change in fair value (5,850 ) Balance at March 31, 2022 $ 1,200 Change in fair value 70 Balance at March 31, 2023 $ 1,270 7.
The following table provides the assets and liabilities carried at fair value on a recurring basis, measured as of March 31, 2024 and 2023 (in thousands): Total Carrying Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) March 31, 2024: Assets: Cash equivalents $ 72,832 $ 72,832 $ — $ — Derivative liabilities: Contingent Consideration $ 3,100 $ — $ — $ 3,100 Total Carrying Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) March 31, 2023: Assets: Cash equivalents $ 7,913 $ 7,913 $ — $ — Derivative liabilities: Contingent Consideration $ 1,270 $ — $ — $ 1,270 50 The table below reflects the activity for the Company’s contingent consideration derivative liability measured at fair value on a recurring basis (in thousands): Acquisition Contingent Consideration Balance at March 31, 2022 $ 1,200 Change in fair value 70 Balance at March 31, 2023 $ 1,270 Change in fair value 4,922 Settlement of contingent consideration (3,092 ) Balance at March 31, 2024 $ 3,100 6.
Changes in the Company’s contract assets, which are included in “Unbilled Accounts Receivable” and “De ferred program costs” (see Note 7, “Accounts Receivable” and Note 8, “Inventory” for a reconciliation to the condensed consolidated balance sheet) and contract liabilities, which are included in the current portion and long term portion of “deferred revenue” in the Company’s condensed consolidated balance sheets, are as follows: Unbilled AR Deferred Program Costs Contract Liabilities Beginning balance as of March 31, 2022 $ 6,492 $ 858 $ 30,034 Increases for costs incurred to fulfill performance obligations — 2,476 — Increase (decrease) due to customer billings (14,373 ) — 77,489 Decrease due to cost recognition on completed performance obligations — (1,189 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 17,839 — (56,643 ) Other changes and foreign currency exchange impact — (9 ) (120 ) Ending balance as of March 31, 2023 $ 9,958 $ 2,136 $ 50,760 Unbilled AR Deferred Program Costs Contract Liabilities Beginning balance as of March 31, 2021 $ 5,765 $ 977 $ 21,257 Increases for balances acquired — 634 10,048 Increases for costs incurred to fulfill performance obligations — 4,814 — Increase (decrease) due to customer billings (16,125 ) — 68,895 Decrease due to cost recognition on completed performance obligations — (5,551 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 16,852 — (70,141 ) Other changes and foreign currency exchange impact — (16 ) (25 ) Ending balance as of March 31, 2022 $ 6,492 $ 858 $ 30,034 The Company’s remaining performance obligations represent the unrecognized revenue value of the Company’s contractual commitments.
Changes in the Company’s contract assets, which are included in “Unbilled accounts receivable” and “De ferred program costs” (see Note 6, “Accounts Receivable” and Note 7, “Inventory” for a reconciliation to the consolidated balance sheets) and "Contract liabilities", which are included in the current portion and long term portion of “Deferred revenue” in the Company’s consolidated balance sheets, are as follows (in thousands): Unbilled AR Deferred Program Costs Contract Liabilities Ending balance as of March 31, 2023 $ 9,958 $ 2,136 $ 50,760 Increases for costs incurred to fulfill performance obligations — 4,411 — Increase (decrease) due to customer billings (20,392 ) — 77,685 Decrease due to cost recognition on completed performance obligations — (4,021 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 16,572 — (70,529 ) Other changes and foreign currency exchange impact 12 (3 ) (87 ) Ending balance as of March 31, 2024 $ 6,150 $ 2,523 $ 57,829 Unbilled AR Deferred Program Costs Contract Liabilities Beginning balance as of March 31, 2022 $ 6,492 $ 858 $ 30,034 Increases for costs incurred to fulfill performance obligations — 2,476 — Increase (decrease) due to customer billings (14,373 ) — 77,489 Decrease due to cost recognition on completed performance obligations — (1,189 ) — Increase (decrease) due to recognition of revenue based on transfer of control of performance obligations 17,839 — (56,643 ) Other changes and foreign currency exchange impact — (9 ) (120 ) Ending balance as of March 31, 2023 $ 9,958 $ 2,136 $ 50,760 The Company’s remaining performance obligations represent the unrecognized revenue value of the Company’s contractual commitments.